Cargando…
Disparity between scientific accomplishment and biotechnology availability in Brazil
Despite being among the world’s leaders in scientific output, Brazil ranks 66th among countries in the production of reagents and supplies needed for state-of-the-art scientific analyses. The production of needed reagents and equipment for experimental analyses and patient diagnostics is sorely lack...
Autores principales: | Braz, Lucia Maria Almeida, Tahmasebi, Roozbeh, da Costa, Antonio Charlys, Witkin, Steven S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454951/ https://www.ncbi.nlm.nih.gov/pubmed/34191659 http://dx.doi.org/10.1177/00368504211028373 |
Ejemplares similares
-
Tegumentary leishmaniasis diagnosis: what happened with MST
(Montenegro Skin Test) in Brazil?
por: Braz, Lucia Maria Almeida
Publicado: (2019) -
Disease X: availability bias, biotechnology and seeing beyond zoonotic risk
por: Armitage, R., et al.
Publicado: (2021) -
Individualized dosing of aminoglycosides in neonates: mission accomplished or work in progress?
por: van den Anker, John N., et al.
Publicado: (2009) -
Quality Assurance for African Laboratories: How Soon can this be Accomplished?
por: Forae, Gerald Dafe
Publicado: (2014) -
Is the regulation of Z-drugs in Brazil in line with scientific research and international standards?
por: de Barros, Víviam Vargas, et al.
Publicado: (2018)